As regular readers of ATLA will know, I like to use thought-provoking quotations in my editorials. Indeed, I am always on the lookout for something which will give me a start, when I am told by my Managing Editor or Production Editor that they must have an editorial within 24 hours. This occasion was no exception. I had two good quotations and I thought that all was well -then it all went wrong.
The first quotation, mentioned in a sermon by Bishop David Leake at St Andrew's Church, East Runton, Norfolk, a few weeks ago, is: As I grow older, I believe more and more in less and less. These are the opening words of the Introduction to a wonderful little book by Canon Dr Alan Hargrave, entitled An Almighty Passion. 1 Having trained as a chemical engineer, Dr Hargrave worked for the Anglican church in Argentina, before being ordained and serving as vicar in a new parish on the edge of Cambridge. He is now Canon Missioner at Ely Cathedral. His thesis is that he believes more and more in the great doctrines of Christianity, and less and less in secondary issues of faith. I absolutely agree with him on that.
I immediately realised that Dr Hargrave's words apply very much to what I now feel about animal experimentation and alternatives. I had no trouble in getting together lists of the things I no longer believe in and of those that I must hold on to at all costs. For example, I don't believe: that the EU REACH system is a manageable and affordable way of protecting human beings and the environment; that the 7th Amendment to the EU Cosmetics Directive can solve the ethical and scientific dilemmas involved in the testing of cosmetic ingredients and products; that EU Directive 63/2010 represents an acceptable advance on Directive 86/609; that the rodent bioassay can be used to identify human carcinogens; that animal studies can be used to identify potential human teratogens; that there can be any ethical and scientific justification for using the higher primates as laboratory animals; and that the humanisation of animals to make them better models of humans is either acceptable or useful -I could go on, and I am sure that the regular readers of ATLA I refer to above, could extend this list for me, but it is already long enough. By contrast, I am confident that non-animal procedures and testing strategies, rigorously developed and intelligently applied, can provide essential information on human diseases, their nature and their treatment, and the risks inherent in exposure to chemicals and products of many kinds -to the benefit of all concerned, humans and animals alike. My confidence is based on what I do believe: that the new and emerging technologies can be ethically applied directly to humans and human-based systems, thus circumventing the problem of species differences and the dubious task of extrapolating knowledge gained from animals to humans and human conditions.
The second quotation, spotted in an advertisement in The Economist (a weekly gift from one of my economist sons), is from The General Theory of Employment, Interest and Money, 2 by John Maynard Keynes, who said: The difficulty lies, not in the new ideas, but in escaping from the old ones, which ramify, for those brought up as most of us have been, into every corner of our minds. This, I thought, would be useful, as a way of considering why so many people seem to be blinkered, and stoically regard animal procedures as virtually the only way of understanding, treating or preventing human disease. Sadly, this inability to escape applies, not only to administrators, lawyers, politicians and regulators, but also to many scientists as well.
A good example of this lamentable situation was recently presented to us, when The Lancet published an Open letter to UK Prime Minister David Cameron and Health Secretary Andrew Lansley on safety of medicines. 3 Kathy Archibald, of the Safer Medicines Trust, and 21 other signatories, had written to our current political leaders to ask them "to initiate a comparison of a set of human-biologybased tests with [the animal tests] currently used, as proposed in the Safety of Medicines Bill 2010-11", since "our reliance on animals to establish safety results in the exposure of clinical volunteers to many treatments that are at best ineffective and at worst dangerous". I fully support that request, but I question why it should be necessary to make it at all. If the Government's advisers were any good, and if the Government listened to them, they would be well aware of worldwide concern in the pharmaceutical industry about the increasing frequency of the withdrawal of drugs during clinical trials, or even after their approval for clinical use, because of the failure of animal ATLA 39, 201-202, 2011 201 Editorial Animal Experiments and Alternatives: Matters of Belief and Trust tests during preclinical testing to predict either lack of efficacy in humans or unacceptable adverse effects in humans. The signatories of the letter say that the response of the UK Department of Health is that "human-based systems have not been established as being more predictive than are animal studies for developing safer medicines". In other words, "we can't accept new procedures, because we cannot escape from our belief in the old ones, whatever evidence is put before us". I was thinking that I could make a suitably thought-provoking editorial out of this unsatisfactory state of affairs, when the bombshell struck.
Another clerical friend of mine, Canon Derek Elton, a theologian with an interest in science, with whom I, as a scientist interested in theology, meet from time to time, to discuss the issues of the day, such as the latest inanities by Richard Dawkins, called to say that he had just read a most compelling article in New Scientist, which I really ought to read.
The article, by Braden Allenby and Daniel Sarewitz, 4 expresses the opinion that: Our world is now so technologically and socially complex that the Enlightenment thinking that spawned it may be more harmful than helpful when it comes to guiding our actions. The main focus of the article is on nuclear power, but their ideas have far wider implications, and they interpret them in terms of three levels of technological complexity.
Allenby and Sarewitz put it like this. Level I "is technology designed to perform a particular function, whose key attributes are integral to the technology itself". At Level II, "a technology is part of a complex network… linked to other complex networks". Level III is "where technology becomes pervasive and is integrated in ways that can never be fully understood". The problem is that "Level I considerations, and to a lesser extent, Level II concerns, dominate our thinking", while "Level III effects are no less real, but tend to get swept under the carpet as unintended consequences that come from beyond the Levels I and II world we consciously seek to create". The result is that "humanity's commitment to technological change is a commitment to the creation of more uncertainty, contingency and incomprehensibility".
This fits with a line of uncomfortable thinking that has disturbed me for some time -a concern that proposals are made and acted upon, often for laudable (Levels I and II) reasons, without their wider (Level III) implications being sufficiently well evaluated. There are many historical examples of this: DDT was sprayed over much of Africa and Asia as a means of eradicating malaria -it didn't, and the result was a harmful build up of DDT in the environment; precious antibiotics were widely used for all kinds of non-essential purposes -then, as infectious agents became resistant to them, and it proved difficult to find effective new antibiotics, diseases returned, now in untreatable forms; animal and plants were taken across the world and released into foreign ecosystems -they spread uncontrollably at great cost to native species. A current example is the laudable proposal to greatly extend the vaccination of children in the Third World, as means of reducing avoidable child mortality -but if these children live, rather than dying, will they have enough to eat and sufficient water to drink? That is the Level III question.
I realise that I am wandering away from the main concerns of ATLA readers, and I could go on to list many examples of where Levels I and II thinking in relation to the use of laboratory animal procedures results in Level III uncertainty and incomprehensibility. That, however, would be unfair and irresponsible, as the Level III problem applies no less to the development and use of nonanimal methods, usually, but not always, developed for good Levels I and II reasons. That is why I have emphasised that the alternative methods must be rigorously developed and intelligently applied -there is a danger that we will have too many methods, some of which will be inadequately developed and insufficiently-well validated, and which may be accepted into practice for emotional, political or commercial reasons. That is why we at FRAME have always believed in the rigorous and independent evaluation of the new methods and their use in intelligent, integrated testing strategies. 5 Not to do so would be unforgivable, and we should be sensitive to Allenby and Sarewitz's final challenge: "What we believe most deeply, we must distrust most strongly". 
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